Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs
- PMID: 34621804
- PMCID: PMC8490625
- DOI: 10.3389/fcvm.2021.745906
Emerging and Established Histological Techniques for the Analysis of Thrombosis in COVID-19 Lungs
Abstract
Coronavirus disease 2019 (COVID-19) is the potentially lethal disease that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with COVID-19 have an increased risk of thrombosis, but the role of thrombosis in the pathogenesis and progression of severe COVID-19 remains unclear. A better understanding of the contribution of thrombosis to the development and progression of COVID-19 could lead to the development of novel COVID-19 treatments. For this reason, established and emerging histological techniques have recently been used to analyze COVID-19 lungs quantitatively and visually and in two and three dimensions. The gold standard and novel state-of the-art histological techniques that have been used to assess thrombosis in COVID-19 lungs are described in this Mini Review.
Keywords: COVID - 19; histology; lung; pulmonary; thrombosis.
Copyright © 2021 Spier and Evans.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Pathogenesis-directed therapy of 2019 novel coronavirus disease.J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10. J Med Virol. 2021. PMID: 33073355 Review.
-
[Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jun 12;43(6):496-502. doi: 10.3760/cma.j.cn112147-20200311-00312. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32241072 Chinese.
-
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.Elife. 2020 Apr 27;9:e57555. doi: 10.7554/eLife.57555. Elife. 2020. PMID: 32338605 Free PMC article.
-
IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).J Biol Regul Homeost Agents. 2020 Sep-Oct,;34(5):1623-1627. doi: 10.23812/20-34-4EDIT-65. J Biol Regul Homeost Agents. 2020. PMID: 32744052
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
Cited by
-
Editorial: Highlights in Thrombosis: 2021.Front Cardiovasc Med. 2022 Feb 24;9:863030. doi: 10.3389/fcvm.2022.863030. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35282334 Free PMC article. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous